vs
Side-by-side financial comparison of Dianthus Therapeutics, Inc. (DNTH) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
Dianthus Therapeutics, Inc. is the larger business by last-quarter revenue ($284.0K vs $182.5K, roughly 1.6× TREASURE GLOBAL INC). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -22687.3%, a 21518.2% gap on every dollar of revenue. On growth, TREASURE GLOBAL INC posted the faster year-over-year revenue change (-12.0% vs -78.6%). TREASURE GLOBAL INC produced more free cash flow last quarter ($-2.4M vs $-47.1M). Over the past eight quarters, Dianthus Therapeutics, Inc.'s revenue compounded faster (-44.6% CAGR vs -83.5%).
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
DNTH vs TGL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0K | $182.5K |
| Net Profit | $-64.4M | $-2.1M |
| Gross Margin | — | 0.7% |
| Operating Margin | -24486.3% | -953.5% |
| Net Margin | -22687.3% | -1169.1% |
| Revenue YoY | -78.6% | -12.0% |
| Net Profit YoY | -126.6% | -124.5% |
| EPS (diluted) | $-1.53 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0K | — | ||
| Q3 25 | $396.0K | $182.5K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | $1.2M | $666.5K | ||
| Q4 24 | $1.3M | $301.9K | ||
| Q3 24 | $2.2M | $207.4K | ||
| Q2 24 | $1.9M | $293.0K | ||
| Q1 24 | $874.0K | $1.6M |
| Q4 25 | $-64.4M | — | ||
| Q3 25 | $-36.8M | $-2.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-29.5M | $1.3M | ||
| Q4 24 | $-28.4M | $-232.3K | ||
| Q3 24 | $-25.2M | $-950.7K | ||
| Q2 24 | $-17.6M | — | ||
| Q1 24 | $-13.7M | $-1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 68.2% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 31.0% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | -24486.3% | — | ||
| Q3 25 | -10173.7% | -953.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | -2852.7% | -6.5% | ||
| Q4 24 | -2406.9% | -229.5% | ||
| Q3 24 | -1376.6% | -391.4% | ||
| Q2 24 | -1191.8% | — | ||
| Q1 24 | -2041.6% | -85.9% |
| Q4 25 | -22687.3% | — | ||
| Q3 25 | -9284.1% | -1169.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | -2537.5% | 189.0% | ||
| Q4 24 | -2144.8% | -77.0% | ||
| Q3 24 | -1159.0% | -458.5% | ||
| Q2 24 | -945.1% | — | ||
| Q1 24 | -1573.0% | -107.3% |
| Q4 25 | $-1.53 | — | ||
| Q3 25 | $-0.97 | $-0.38 | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.82 | $1.09 | ||
| Q4 24 | $-0.76 | $-11.32 | ||
| Q3 24 | $-0.74 | $-17.62 | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.54 | $-116.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $404.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $493.4M | $12.0M |
| Total Assets | $530.9M | $16.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $404.3M | — | ||
| Q3 25 | $402.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $263.2M | $2.5K | ||
| Q4 24 | $275.2M | $504.3K | ||
| Q3 24 | $281.1M | $44.1K | ||
| Q2 24 | $360.7M | $171.6K | ||
| Q1 24 | $377.0M | — |
| Q4 25 | $493.4M | — | ||
| Q3 25 | $546.5M | $12.0M | ||
| Q2 25 | — | $10.7M | ||
| Q1 25 | $328.6M | $29.1M | ||
| Q4 24 | $352.5M | $18.4M | ||
| Q3 24 | $337.9M | $6.3M | ||
| Q2 24 | $358.2M | $3.4M | ||
| Q1 24 | $372.7M | $3.1M |
| Q4 25 | $530.9M | — | ||
| Q3 25 | $577.4M | $16.6M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | $348.6M | $30.4M | ||
| Q4 24 | $374.0M | $19.1M | ||
| Q3 24 | $354.2M | $7.1M | ||
| Q2 24 | $369.0M | $4.3M | ||
| Q1 24 | $382.5M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.0M | $-1.8M |
| Free Cash FlowOCF − Capex | $-47.1M | $-2.4M |
| FCF MarginFCF / Revenue | -16591.9% | -1318.2% |
| Capex IntensityCapex / Revenue | 48.6% | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-132.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.0M | — | ||
| Q3 25 | $-30.6M | $-1.8M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | $-27.6M | $-4.2M | ||
| Q4 24 | $-27.4M | $-606.2K | ||
| Q3 24 | $-21.3M | $-976.3K | ||
| Q2 24 | $-14.5M | $-4.7M | ||
| Q1 24 | $-14.9M | $-1.1M |
| Q4 25 | $-47.1M | — | ||
| Q3 25 | $-30.6M | $-2.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | $-27.7M | $-4.2M | ||
| Q4 24 | $-27.5M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-14.5M | $-4.7M | ||
| Q1 24 | $-15.0M | $-1.1M |
| Q4 25 | -16591.9% | — | ||
| Q3 25 | -7717.2% | -1318.2% | ||
| Q2 25 | — | -822.4% | ||
| Q1 25 | -2377.8% | -635.6% | ||
| Q4 24 | -2072.0% | — | ||
| Q3 24 | -980.3% | — | ||
| Q2 24 | -780.7% | -1614.2% | ||
| Q1 24 | -1713.2% | -67.1% |
| Q4 25 | 48.6% | — | ||
| Q3 25 | 1.3% | 353.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | 2.1% | 0.3% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.9% | 5.7% | ||
| Q1 24 | 3.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
